Hawkins, Inc. (NASDAQ:HWKN) Shares Purchased by Bridges Investment Management Inc.

Bridges Investment Management Inc. lifted its stake in shares of Hawkins, Inc. (NASDAQ:HWKN - Free Report) by 111.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 9,289 shares of the specialty chemicals company's stock after purchasing an additional 4,888 shares during the quarter. Bridges Investment Management Inc.'s holdings in Hawkins were worth $984,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the company. Vermillion Wealth Management Inc. bought a new stake in shares of Hawkins during the 4th quarter worth $34,000. NewEdge Advisors LLC purchased a new position in shares of Hawkins in the fourth quarter worth $53,000. GAMMA Investing LLC grew its position in shares of Hawkins by 20.4% in the 1st quarter. GAMMA Investing LLC now owns 531 shares of the specialty chemicals company's stock worth $56,000 after buying an additional 90 shares during the last quarter. TD Private Client Wealth LLC lifted its position in shares of Hawkins by 40.0% in the 1st quarter. TD Private Client Wealth LLC now owns 661 shares of the specialty chemicals company's stock worth $70,000 after purchasing an additional 189 shares during the period. Finally, Nisa Investment Advisors LLC boosted its position in Hawkins by 26.4% during the 1st quarter. Nisa Investment Advisors LLC now owns 981 shares of the specialty chemicals company's stock valued at $104,000 after acquiring an additional 205 shares in the last quarter. Hedge funds and other institutional investors own 69.71% of the company's stock.

Hawkins Trading Down 0.3%

NASDAQ:HWKN traded down $0.42 during mid-day trading on Friday, hitting $155.30. 310,009 shares of the stock traded hands, compared to its average volume of 133,326. The firm's 50 day moving average is $134.88 and its two-hundred day moving average is $120.33. The stock has a market capitalization of $3.24 billion, a price-to-earnings ratio of 38.44, a PEG ratio of 2.59 and a beta of 0.85. The company has a quick ratio of 1.37, a current ratio of 2.15 and a debt-to-equity ratio of 0.30. Hawkins, Inc. has a 52 week low of $98.08 and a 52 week high of $156.61.

Hawkins (NASDAQ:HWKN - Get Free Report) last issued its earnings results on Wednesday, May 14th. The specialty chemicals company reported $0.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.74 by $0.04. The company had revenue of $245.32 million for the quarter, compared to analysts' expectations of $230.69 million. Hawkins had a net margin of 8.66% and a return on equity of 18.93%. On average, equities research analysts predict that Hawkins, Inc. will post 4 earnings per share for the current year.

Hawkins Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 30th were given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.46%. The ex-dividend date was Friday, May 30th. Hawkins's dividend payout ratio is presently 17.82%.

Analyst Ratings Changes

Several equities research analysts recently commented on HWKN shares. Wall Street Zen lowered shares of Hawkins from a "buy" rating to a "hold" rating in a research note on Saturday, July 5th. CJS Securities started coverage on shares of Hawkins in a research report on Tuesday, April 1st. They issued a "market outperform" rating and a $125.00 price target on the stock. Finally, BWS Financial reiterated a "buy" rating and issued a $160.00 price target on shares of Hawkins in a research note on Thursday, May 15th.

About Hawkins

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.